CDKN2B and Stroke: Cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) spans approximately 126.3 kb, overlaps with cyclin-dependent kinase inhibitor 2B (CDKN2B) (p15) at the 5 ́ end, comprises 20 exons that are prone to alternative splicing and is reported to be linked to CAD risk, hypertension (HTN) and stroke [13].